USANA Health Sciences, Inc. (NYSE:USNA) Shares Sold by AQR Capital Management LLC

AQR Capital Management LLC trimmed its holdings in USANA Health Sciences, Inc. (NYSE:USNA) by 22.4% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 11,428 shares of the company’s stock after selling 3,293 shares during the period. AQR Capital Management LLC’s holdings in USANA Health Sciences were worth $517,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in USNA. CWM LLC boosted its stake in USANA Health Sciences by 21.8% in the 1st quarter. CWM LLC now owns 1,543 shares of the company’s stock worth $75,000 after buying an additional 276 shares during the last quarter. First Hawaiian Bank boosted its stake in USANA Health Sciences by 22.3% in the 1st quarter. First Hawaiian Bank now owns 9,089 shares of the company’s stock worth $441,000 after buying an additional 1,656 shares during the last quarter. DGS Capital Management LLC boosted its stake in USANA Health Sciences by 61.8% in the 1st quarter. DGS Capital Management LLC now owns 7,258 shares of the company’s stock worth $352,000 after buying an additional 2,773 shares during the last quarter. BNP Paribas Financial Markets boosted its stake in USANA Health Sciences by 18.1% in the 1st quarter. BNP Paribas Financial Markets now owns 38,820 shares of the company’s stock worth $1,883,000 after buying an additional 5,952 shares during the last quarter. Finally, Pzena Investment Management LLC boosted its stake in USANA Health Sciences by 3.1% in the 1st quarter. Pzena Investment Management LLC now owns 785,344 shares of the company’s stock worth $38,089,000 after buying an additional 23,729 shares during the last quarter. 54.25% of the stock is owned by institutional investors and hedge funds.

USANA Health Sciences Price Performance

NYSE USNA opened at $35.62 on Tuesday. The firm has a market capitalization of $678.60 million, a P/E ratio of 11.10, a P/E/G ratio of 1.20 and a beta of 0.89. USANA Health Sciences, Inc. has a 1-year low of $34.76 and a 1-year high of $57.78. The business’s 50-day simple moving average is $38.39 and its 200-day simple moving average is $43.05.

USANA Health Sciences (NYSE:USNA) last released its quarterly earnings data on Tuesday, July 23rd. The company reported $0.54 earnings per share for the quarter, missing the consensus estimate of $0.65 by ($0.11). The firm had revenue of $212.87 million during the quarter, compared to analyst estimates of $218.64 million. USANA Health Sciences had a net margin of 6.29% and a return on equity of 11.13%. During the same period in the prior year, the firm earned $0.89 earnings per share. On average, equities research analysts expect that USANA Health Sciences, Inc. will post 2.5 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

USNA has been the topic of a number of research analyst reports. StockNews.com lowered USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 24th. DA Davidson reduced their price objective on USANA Health Sciences from $46.00 to $38.00 and set a “neutral” rating on the stock in a research note on Thursday, July 25th.

Insiders Place Their Bets

In other USANA Health Sciences news, insider Paul A. Jones sold 6,266 shares of the company’s stock in a transaction that occurred on Tuesday, August 13th. The stock was sold at an average price of $38.38, for a total value of $240,489.08. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other USANA Health Sciences news, Director Gilbert A. Fuller sold 674 shares of the company’s stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $39.69, for a total value of $26,751.06. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Paul A. Jones sold 6,266 shares of the company’s stock in a transaction that occurred on Tuesday, August 13th. The shares were sold at an average price of $38.38, for a total value of $240,489.08. The disclosure for this sale can be found here. Insiders sold a total of 7,940 shares of company stock worth $311,670 in the last 90 days. 0.33% of the stock is owned by company insiders.

USANA Health Sciences Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.